level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Jayendrakumar P.に依頼
India

M.Pharma, Ph.D.(Pr.), MBA, FSFRC, FIPES, IAOTP Honoured Member

プロフィール概要
専門分野
サービス
Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting
Research User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Systematic Literature Review
Consulting Regulatory Consulting
Data & AI Statistical Analysis, Data Processing, Data Insights
Product Development Formulation, Stability/Shelf Life Testing, Material Sourcing, Product Validation, Manufacturing, Concept Development
職務経験

Ganpat University

1月 2020 - 現在

Technical Lead

Natoli Engineering Company, USA

10月 2019 - 現在

Director & Chief Executive Officer

Pyrrhic Pharma Private Limited

10月 2019 - 現在

Research Scientist

Xylopia Lab Private Limited

7月 2019 - 9月 2019

Deputy Manager

Zydus Cadila

8月 2014 - 6月 2019

Research Scientist

Alkem Laboratories Ltd

3月 2014 - 8月 2014

Research Assistant

Sun Pharma Advanced Research (India)

7月 2011 - 3月 2014

学歴

Ph.D. (Pharmaceutical Science)

Ganpat University

- 現在

Master in Industrial Pharmacy (M. Pharma)

Ganpat University

2009 - 2011

認定資格
  • 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel, Ronak Patel, Payalben Patel (2021). Carbon Nanotube (CNTs): Structure, Synthesis, Purification, Functionalisation, Pharmacology, Toxicology, Biodegradation and Application as Nanomedicine and Biosensor . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). Role of Secondary Attack Rate in The Surge of COVID 19 Cases: A Comparative Retrospective Cohort Study between First Wave and Second Wave of COVID 19 . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). A Comprehensive Overview On The Most Recent Trends In Covid-19 Diagnosis, Treatment Options And Vaccine Development Status . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Shalin Parikh, Ronak Patel, Shwetaben Patel(2021). Art Of Designing A Novel Drug Formulation With Patient In Mind . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). Fabrication And In-Vitro Analysis Of Mouth Dissolving Tablets Of Ondansetron Using Water Insoluble Super Disintegrant . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Mamta Nasit, Meshva Patel, Ajay Solanki(2021). Solid-State Lipid - Based Lipid Drug Delivery System . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
OTHER
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel(2021). Unrestricted Social Interaction: Underappreciated Cause of COVID 19 Surge . Research Square Platform {LLC}
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .
CONFERENCE POSTER
(2011). Formulation and Development of Single layer osmotic controlled release tablet of Sertraline Hydrochloride.
PATENT
A Novel Oral Gastroretentive Pharmaceutical Dosage Form.
A Novel Pulsatile Drug Delivery System.
Abuse Deterrent Pharmaceutical Composition: Therapeutically Effective For A Patient And Deterrent To An Abuser.
Extended Release Osmotic Dosage Forms Comprising High Methylphenidate Hydrochloride Load.
Pharmaceutical Abuse Deterrent Composition Constructed in More Than One Strength.
Pharmaceutical Abuse Deterrent Dosage Form.
Tamper Resistant Pharmaceutical Composition.